Authors

Michael Chuong, Baptist Health Medical Group; Miami Cancer InstituteFollow

Neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreas adenocarcinoma: influence of vascular margin status and type of chemotherapy

Publication Date

5-2023

Content Type

Article

Publisher's Site:

View at Publisher Website

Additional Authors:

Additional authors and institutional affiliations

Citation

Palm, R. F., Boyer, E., Kim, D. W., Denbo, J., Hodul, P. J., Malafa, M., Fleming, J. B., Shridhar, R., Chuong, M. D., Mellon, E. A., Frakes, J. M., & Hoffe, S. E. (2023, 2023/09/01/). Neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreas adenocarcinoma: influence of vascular margin status and type of chemotherapy. HPB, 25(9), 1110-1120. https://doi.org/https://doi.org/10.1016/j.hpb.2023.04.019